Inhibition of CK1e potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer

ABSTRACT: In this study, we found that combination treatment of breast cells with CK1 inihbitor (D 4476) and CDK4/6 inhibitor (Ribociclib) exhibited greatly enhanced therapeutic efficacy than CDK4/6 inhiitor single treatment

ORGANISM(S): Homo sapiens

PROVIDER: GSE177054 | GEO | 2021/08/10

REPOSITORIES: GEO